-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2023.
- Evelo Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$12.4M, a 59.5% increase year-over-year.
- Evelo Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$82.3M, a 31.2% increase year-over-year.
- Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$115M, a 6.26% increase from 2021.
- Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$122M, a 30.4% decline from 2020.
- Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$93.7M, a 9.59% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)